C
Amgen Inc. AMGN
$280.84 $1.000.36% NASDAQ
Recommendation
Prev Close
$280.84
Volume
1,994,615
Avg Vol (90D)
3,279,926
Market Cap
$150.99B
Dividend & Yield
$9.13(3.25%)
52-Week Range
$253.30 - $346.85
P/E (TTM)
37.21
EPS (TTM)
$7.55
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Earnings Miss? Amgen’s Dividend Still a Bright Spot
2/5/2025 - MarketBeat
Amgen (NasdaqGS:AMGN) Expands Ohio Facility With US$900 Million Investment
4/26/2025 - Simply Wall St
Amgen (AMGN) Invests $900 Million in Ohio Expansion
4/26/2025 - GuruFocus
Hancock Whitney Corp Sells 2,474 Shares of Amgen Inc. (NASDAQ:AMGN)
4/26/2025 - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Position Trimmed by Adage Capital Partners GP L.L.C.
4/26/2025 - MarketBeat
Amgen (AMGN) Projected to Post Quarterly Earnings on Thursday
4/26/2025 - MarketBeat
Amgen to invest $900 million in New Albany expansion, nearly doubling job creation
4/25/2025 - Bizjournals.com - Health Care News
Amgen (AMGN) Expands Ohio Biomanufacturing Plant with $900M Investment
4/25/2025 - GuruFocus
AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO AMGN ...
4/25/2025 - GuruFocus
AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO
4/25/2025 - GuruFocus
Amgen Inc (AMGN) Announces $900 Million Expansion in Ohio, Creating 350 New Jobs AMGN stock news
4/25/2025 - GuruFocus
Amgen (AMGN) Expands Ohio Facility with Additional $900M Investment AMGN Stock News
4/25/2025 - GuruFocus
Amgen to expand Ohio biotech manufacturing plant
4/25/2025 - Yahoo! Finance: News
Amgen announces $900M manufacturing expansion, creation of 350 new jobs
4/25/2025 - The Fly
AMGEN ANNOUNCES $900 MILLION MANUFACTURING EXPANSION, CREATION OF 350 NEW JOBS IN OHIO
4/25/2025 - PR Newswire
Amgen to spend $900M to expand Ohio drugmaking plant
4/25/2025 - Seeking Alpha - Healthcare
Amgen to spend $900M to expand Ohio drugmaking plant
4/25/2025 - SeekingAlpha.com: All News
industrys onshoring tide rolling amgen blueprints 900m expansion ohio
4/25/2025 - FiercePharma
CytomX Gears Up to Report Q1 Earnings: Here's What to Expect
4/25/2025 - Zacks Investment Research
Voya Financial Advisors Inc. Sells 64 Shares of Amgen Inc. (NASDAQ:AMGN)
4/25/2025 - Ticker Report
CSM Advisors LLC Raises Stock Position in Amgen Inc. (NASDAQ:AMGN)
4/25/2025 - MarketBeat
Pinebridge Investments L.P. Purchases 86,927 Shares of Amgen Inc. (NASDAQ:AMGN)
4/25/2025 - MarketBeat
Q1 Earnings Scorecard and Analyst Reports for Costco, American Express & Goldman Sachs
4/24/2025 - Zacks Investment Research
Novo Nordisk Plunges 17% in a Month: Buy, Sell or Hold the Stock?
4/24/2025 - Zacks Investment Research
Amgen (AMGN) Earnings Expected to Grow: Should You Buy?
4/24/2025 - Zacks Investment Research
Income Statement
Total Revenue (TTM)
$33.42B
EBITDA (TTM)
$15.16B
EBIT (TTM)
$9.68B
Net Income (TTM)
$4.09B
Balance Sheet
Total Assets (Q)
$91.84B
Total Debt (Q)
$60.88B
Total Liabilities (Q)
$85.96B
Book Value Per Share (Q)
$10.95
Cash Flow
Cash from Operations (TTM)
$11.49B
Cash from Investing (TTM)
-$1.05B
Cash from Financing (TTM)
-$9.42B
Net Change in Cash (TTM)
$1.03B
Filings
Filing Date
Friday, February 14, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Beginning of May (est)
Price History
Loading...
Beta
0.33
7-Day Total Return
-0.64%
30-Day Total Return
-10.48%
60-Day Total Return
-0.32%
90-Day Total Return
4.61%
Year to Date Total Return
9.19%
1-Year Total Return
7.20%
2-Year Total Return
25.27%
3-Year Total Return
23.52%
5-Year Total Return
35.08%
52-week Low
Dec 19, 2024 - $253.30
52-week High
Jul 25, 2024 - $346.85
Valuation
Market Cap
$150.99B - Large Cap
Enterprise Value
$199.90B
Price/Sales (TTM)
4.55
Price/Book (Q)
25.66
Dividends and Shares
Shares Outstanding
542.00M
Dividend Per Share (Most Recent)
$2.38
Dividend Per Share (TTM)
$9.13
Corporate Info
Website
www.amgen.com
Phone Number
805 447 1000
Address
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
Country
United States
Year Founded
1980
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company’s principal products include Enbrel for the treatment of rheumatoid arthritis, plaque... more
NASDAQ 04/25/2025 4:00PM Eastern Quotes delayed